diffuse large B-cell lymphoma
Columvi Granted Accelerated Approval For Selected Relapsed or Refractory Large B-cell Lymphomas
The FDA granted accelerated approval for glofitamab-gxbm (Columvi, Genentech) for the treatment of adult patients ...
JUNE 21, 2023
Polivy Approved for Previously Untreated DLBCL, Not Otherwise Specified, or High-Grade B-Cell Lymphoma
The FDA approved Polivy with R-CHP for adult patients who have previously untreated DLBCL, not otherwise specified, ...
MAY 10, 2023
Rituxan Hycela Approved for FL, DLBCL, CLL
Rituximab and hyaluronidase human (Rituxan Hycela, Genentech) was approved for subcutaneous injection for the ...
JUNE 23, 2017
Load more